#growth hormone

1 article

Approach: Data as art, with a conceptual twist. Palette: bold color field (D).

Subject: a single glass syringe lying on a saturated mustard-yellow acrylic surface, shot from a low three-quarter angle with a shallow depth of field. Behind it, a long arc of thin copper wire rises in a gentle curve from a small spike to a broad plateau and then slowly tapers, echoing a hormone curve stretched across days. Small, evenly spaced glass beads sit along the wire, each slightly larger toward the plateau. One bead glows soft electric green.

Lighting: hard single softbox from the upper left, creating crisp, short shadows in warm umber on the yellow. Specular highlights on the glass and copper.

Mood: precise, patient, and quietly analytical, with a slow-release rhythm. No text or markings anywhere.

CJC‑1295 – ljudsko ispitivanje: što originalni podaci o GH i IGF‑1 pokazuju

BY HELIX WARD · 19. lis 2026.

Jedna injekcija CJC‑1295 podigla je hormon rasta 2 – 10 puta tijekom šest dana ili više i IGF‑1 1,5 – 3 puta tijekom 9 – 11 dana kod zdravih odraslih osoba (21‑61 godina). Poluvrijeme peptida procijenjeno je na 5,8 – 8,1 dana, a IGF‑1 je ostao iznad početne razine do 28 dana nakon ponovljenog doziranja. Nisu prijavljene ozbiljne nuspojave, a doze od 30 – 60 µg/kg najbolje su tolerirane. Ispitivanje iz 2006. godine mjerilo je hormone i sigurnost, a ne mišićnu masu, masnoću ili performanse. Evo što originalni podaci stvarno pokazuju, kako se CJC‑1295 s DAC razlikuje od mod GRF 1‑29 i zašto je ovaj peptid i dalje neodobren, a WADA‑om zabranjen.